EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. (Q39021976)

8 September 2017

title

EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. (English)

1 reference

8 September 2017

1 reference

Shaoyi Li

1

1 reference

8 September 2017

Yun Gao

2

1 reference

8 September 2017

Weining Ma

3

1 reference

8 September 2017

Wenchang Guo

4

1 reference

8 September 2017

Gang Zhou

5

1 reference

8 September 2017

Tianci Cheng

6

1 reference

8 September 2017

Yunhui Liu

7

1 reference

8 September 2017

publication date

21 February 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

5593-5598

1 reference

Genomics informs glioblastoma biology

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Time and dose-dependent radiosensitization of the glioblastoma multiforme U251 cells by the EGF receptor tyrosine kinase inhibitor ZD1839 ('Iressa').

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Genetic variations in EGF and EGFR and glioblastoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Targeting the unfolded protein response in glioblastoma cells with the fusion protein EGF-SubA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-014-1739-X

Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice

21 January 2018

1 reference

12 December 2020

Simultaneous measurement of cell cycle and apoptotic cell death

1 reference

12 December 2020

In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors

1 reference

12 December 2020

[Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary]

1 reference

12 December 2020

Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo

1 reference

12 December 2020

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

12 December 2020

Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells

1 reference

12 December 2020

10.1007/S13277-014-1739-X

Identifiers

DOI

1 reference

8 September 2017

1 reference